Literature DB >> 17638897

Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells.

Mourad Majidi1, Hussein A Al-Wadei, Takashi Takahashi, Hildegard M Schuller.   

Abstract

Women are at higher risk for the development of lung adenocarcinoma than men; however, the mechanisms responsible for this are poorly understood. In lung adenocarcinoma cells, the estrogen receptor beta (ERbeta) is the predominating form. We found that 17beta-estradiol enhanced proliferation of the putative cells of origin of lung adenocarcinoma, small airway epithelial cells (HPLD1), in response to the nicotine-derived nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Reverse-phase protein microarrays combined with Western blotting revealed that NNK induced phosphorylation of ERbeta, an effect that involved stimulation of the adrenergic receptors beta1 (beta1AR). In transiently transfected cells, beta1AR coprecipitated with ERbeta, which increased with NNK treatment. ERbeta enhanced NNK-induced cyclic AMP accumulation as well as Galphai-mediated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) 1/2 activation. Coexpression of beta1AR and ERbeta activated NNK-mediated ERK1/2 cooperatively. ERbeta gene knockdown, as well as coexpression of the dominant negative Ras and Raf, reduced stimulation of ERK1/2 by NNK. Whereas NNK phosphorylated Akt at Thr(308) and Ser(473), ERbeta had no effect on this activity. Luciferase reporter assays showed that, in response to NNK, ERbeta stimulated transcription of serum responsive element (SRE) but had a very small effect on the activity of estrogen responsive element (ERE). Together, the phosphorylation of ERbeta, the dependence on Galphai proteins, the activation of ERK1/2, and the preferential targeting of SRE over the classic ERE pathway support a role for nongenomic ERbeta in the development of smoking-associated lung cancer. This novel cooperation between beta1AR and ERbeta signaling may contribute to the prominence of lung adenocarcinoma in women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638897     DOI: 10.1158/0008-5472.CAN-07-0483

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention.

Authors:  Hildegard M Schuller; Hussein A N Al-Wadei; Mohammad F Ullah; Howard K Plummer
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

2.  Social stress promotes and γ-aminobutyric acid inhibits tumor growth in mouse models of non-small cell lung cancer.

Authors:  Hussein A N Al-Wadei; Howard K Plummer; Mohammad F Ullah; Benjamin Unger; Joel R Brody; Hildegard M Schuller
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-28

3.  Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells.

Authors:  Pamela A Hershberger; Laura P Stabile; Beatriz Kanterewicz; Mary E Rothstein; Chris T Gubish; Stephanie Land; Yongli Shuai; Jill M Siegfried; Mark Nichols
Journal:  J Steroid Biochem Mol Biol       Date:  2009-05-19       Impact factor: 4.292

Review 4.  Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?

Authors:  Hildegard M Schuller
Journal:  Nat Rev Cancer       Date:  2009-02-05       Impact factor: 60.716

5.  Beta-adrenergic signaling in the development and progression of pulmonary and pancreatic adenocarcinoma.

Authors:  Hildegard M Schuller; Hussein A N Al-Wadei
Journal:  Curr Cancer Ther Rev       Date:  2012-05-01

6.  Mitochondrial estrogen receptor β inhibits cell apoptosis via interaction with Bad in a ligand-independent manner.

Authors:  Jiayi Liang; Qiang Xie; Ping Li; Xueyun Zhong; Yunxian Chen
Journal:  Mol Cell Biochem       Date:  2014-12-19       Impact factor: 3.396

7.  Nicotinic receptor-associated modulation of stimulatory and inhibitory neurotransmitters in NNK-induced adenocarcinoma of the lungs and pancreas.

Authors:  Hussein A N Al-Wadei; Hildegard M Schuller
Journal:  J Pathol       Date:  2009-08       Impact factor: 7.996

8.  Nonsteroidal anti-inflammatory drug-activated gene-1 expression inhibits urethane-induced pulmonary tumorigenesis in transgenic mice.

Authors:  Maria Cekanova; Seong-Ho Lee; Robert L Donnell; Mugdha Sukhthankar; Thomas E Eling; Susan M Fischer; Seung Joon Baek
Journal:  Cancer Prev Res (Phila)       Date:  2009-04-28

9.  Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells.

Authors:  Guangfeng Zhang; Xuwan Liu; Adam M Farkas; Anil V Parwani; Kira L Lathrop; Diana Lenzner; Stephanie R Land; Harish Srinivas
Journal:  Mol Endocrinol       Date:  2008-12-23

10.  Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.

Authors:  Adriana Aguilar-Mahecha; Christiane Cantin; Maureen O'Connor-McCourt; Andre Nantel; Mark Basik
Journal:  Proteome Sci       Date:  2009-04-06       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.